Linking Ubiquitin Research to Drug Discovery

Home » News & Events

Ubiquitin focused drug discovery

Posted on August 3rd, 2017 in News
Targeting kinase enzymes has grown to dominate drug discovery over the last decade, accounting for 30% of current pharma R&D Click on the link below to download our brochure detailing "The Unbiquitin System" and how "The analogous ubiquitin cell signalling… Read more

DUBtarget™-001 – a novel DUB focused compound library

Posted on August 3rd, 2017 in News
The first compound library comprising novel small molecules designed to target deubiquitylase enzymes Click on the link below to download a non-confidential summary of DUBtarget™-001 which includes details of how the library was designed and characterised by screening it using… Read more

SCI: Targeting the Ubiquitin-Proteasome Pathway (19th May 2017)

Posted on March 31st, 2017 in Events
Ubiquigent will be attending and presenting at the upcoming SCI meeting - Targeting the Ubiquitin - Proteasome Pathway on 19th May 2017 at the Studio, Birmingham. If you would like to hear more about our novel ubiquitin system compound libraries… Read more

Ubiquigent awarded Innovate UK grant

Posted on January 19th, 2017 in News
Ubiquigent awarded Innovate UK grant to develop novel compound libraries targeting deubiquitylase (DUB) enzymes Dundee, UK, 19th January 2017: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it has… Read more

Ubiquigent attending Bio Europe 2016 – Cologne, Germany (7th-9th Nov)

Posted on October 31st, 2016 in Events
We will be attending the upcoming Bio Europe 2016 conference in Cologne, Germany from 7th - 9th November. Full details of the conference can be found here. If you would like to meet with us at Bio Europe, please either contact us… Read more

Ubiquigent launches first novel compound library

Posted on September 14th, 2016 in News
Ubiquigent launches the first novel compound library designed to target Deubiquitylase (DUB) enzymes - DUBtarget™-001 Dundee, UK, 14th September, 2016: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it… Read more

Targeted chemical libraries: the keys to unlock the ubiquitin system

Posted on September 8th, 2016 in Events
Meet Ubiquigent at the upcoming SCI meeting on the 14th September, Hatfield, UK- Innovation in design, supply and acquisition for compound screening libraries Dr John Harris CChem FRSC, Member of Scientific Advisory Board, Ubiquigent Ltd will be giving a short… Read more

Horizon & Ubiquigent Enter into Collaboration Agreement

Posted on May 26th, 2016 in News
Horizon's X-MAN® cell lines to be made available in conjunction with Ubiquigent's ubiquitin-related Drug Discovery Services   Cambridge, UK, 26 May 2016: Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies including… Read more

Dundee, UK – the place to access world class ubiquitin system research expertise and capabilities

Posted on May 12th, 2016 in News
Take a look at a great article that was published today in Nature describing how the Division of Signal Transduction Therapy (DSTT) enables pre-competitive access to ubiquitin system research at the University of Dundee. Our friends at the University of… Read more

Ubiquigent Strengthens Team to Deliver Cutting Edge Drug Discovery Services, Research Tools and Chemistry and Announces Launch of New Website

Posted on February 24th, 2016 in News
Dundee, UK, 24th February, 2016: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it has significantly enhanced its drug discovery service capabilities by strengthening its commercial and chemistry teams… Read more